| A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib (NCT01712217) | Astex Pharmaceuticals, Inc. | 2012-10-01 |
| Pilot Study of X-82 in Patients With Wet AMD (NCT01674569) | Tyrogenex | 2012-10-01 |
| BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients (NCT01624493) | Hoosier Cancer Research Network | 2012-10-01 |
| Effect of Vitamin D3 Supplementation in Pregnancy on Risk of Pre-eclampsia (NCT03101150) | King Fahad Medical City | 2012-10-01 |
| Multiple Ascending Dose Study of GLPG0974 in Healthy Subjects (NCT01721980) | Lakefront Biotherapeutics NV | 2012-10-01 |
| Bioequivalence Study of Etodolac Capsules USP 300 mg Under Fed Condition (NCT01749228) | IPCA Laboratories Ltd. | 2012-10-01 |
| A Safety, Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors (NCT01664000) | Cellceutix Corporation | 2012-10-01 |
| A Study of ABT-414 in Subjects With Solid Tumors (NCT01741727) | AbbVie (prior sponsor, Abbott) | 2012-10-01 |
| A Study to Explore Pharmacokinetic Interaction Between Rilpivirine and Metformin in Healthy Participants (NCT01719614) | Janssen R&D Ireland | 2012-10-01 |
| Safety and Preliminary Efficacy Study of the Antibody PAT-SM6 in Patients With Relapsed or Refractory Multiple Myeloma (NCT01727778) | Patrys Ltd. | 2012-10-01 |
| Enteral Administration of Docosahexaenoic Acid to Prevent Necrotizing Enterocolitis in Preterm Neonates (NCT01745510) | Coordinación de Investigación en Salud, Mexico | 2012-10-01 |
| Comparison of Absorption of Vaginal Diazepam Using Different Delivery Systems (NCT01696825) | Jason Gilleran | 2012-10-01 |
| A Phase I, Safety Study of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Children (NCT01712906) | Institute of Medical Biology, Chinese Academy of Medical Sciences | 2012-10-01 |
| Preoperative Warm-up in Gynecologic Surgery (NCT01712607) | Medical University of Vienna | 2012-10-01 |
| A Study to Assess the Effect of Food on the Bioavailability of the IGF-1R Inhibitor AXL1717 in Patients With Advanced Malignant Tumors (NCT01725555) | Axelar AB | 2012-10-01 |
| A Study of LY3039478 in Participants With Advanced Cancer (NCT01695005) | Eli Lilly and Company | 2012-10-01 |
| Muscle Protein Metabolism in Obesity (NCT01824173) | Mayo Clinic | 2012-10-01 |
| Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells (NCT01783431) | Medical University of South Carolina | 2012-10-01 |
| Study of Theliatinib (HMPL-309) in Patients With Advanced Solid Tumor (NCT02601248) | Hutchison Medipharma Limited | 2012-10-01 |
| Tivantinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors (NCT01725191) | National Cancer Institute (NCI) | 2012-10-01 |
| A Pilot Study of ALTENS in Improving Dysphagia Induced by IMRT for Head and Neck Cancers (NCT01697891) | McMaster University | 2012-10-01 |
| Reducing Dyskinesia in Parkinson's Disease With Omega-3 Fatty Acids (NCT01563913) | VA Office of Research and Development | 2012-10-01 |
| Clinical Effect of Phenytoin Mucoadhesive Paste on Wound Healing After Oral Biopsy (NCT01680042) | Shahid Beheshti University of Medical Sciences | 2012-10-01 |
| Study to Investigate the Pharmacolkinetics of Aldoxorubicin (INNO-206;DOXO-EMCH) Administered as a 30 Minute Infusion Every 3 Weeks in Subjects With Advanced Solid Tumors (NCT01706835) | ImmunityBio, Inc. | 2012-10-01 |
| Effects of Mexiletine on Colonic Transit in a Patient With Irritable Bowel Syndrome - Constipation (IBS-C) (NCT01717404) | Mayo Clinic | 2012-10-01 |
| Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma. (NCT01721018) | Virttu Biologics Limited | 2012-10-01 |
| Establishing and Eliminating Cue-drug Associations in Human Cocaine Addiction (NCT01978457) | Yale University | 2012-10-01 |
| Trial to Assess the Influence of 4 Weeks' Treatment With Linagliptin as Compared to Glimepiride and Placebo on Endothelial Function in Patients With Type 2 Diabetes Using FMD (Flow-Mediated Vasodilation) (NCT01703286) | Boehringer Ingelheim | 2012-10-01 |
| A Multipeptide Vaccine Plus Toll-Like Receptor Agonists in Melanoma Patients (NCT01585350) | Craig L Slingluff, Jr | 2012-10-01 |
| Self-Management in Stroke Survivors (NCT01875094) | University of Minnesota | 2012-10-01 |
| Safety and Efficacy Study of Autologus Bone Marrow Mesenchymal Stem Cells in Multiple Sclerosis (NCT01895439) | University of Jordan | 2012-10-01 |
| BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone (NCT01662674) | LG Life Sciences | 2012-10-01 |
| A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and Lymphomas (NCT02048488) | Tesaro, Inc. | 2012-10-01 |
| Study of ST266 Versus Saline in Treating Skin Irritation From Radiation (NCT01714973) | Noveome Biotherapeutics, formerly Stemnion | 2012-10-01 |
| Evaluation Of The Potential Effect That The Administration Of Food Or Antacid Medication May Have In The Oral Absorption Of Dacomitinib (PF-00299804) (NCT01702506) | Pfizer | 2012-10-01 |
| Effectiveness of P02 Digital Hearing Aids (NCT01902914) | Khon Kaen University | 2012-10-01 |
| Descriptive Study of Strength Training Exercises to Activate the Muscles of the Operated Leg After Total Knee Replacement (NCT01708980) | Copenhagen University Hospital, Hvidovre | 2012-10-01 |
| An Study to Determine the Bioavailability of E2609 Tablets Compared to Capsules and the Effect of Food on Absorption (NCT01716897) | Eisai Inc. | 2012-10-01 |
| Open-Trial of EPI-743 for Adults With Tourette Syndrome (NCT01719523) | Yale University | 2012-10-01 |
| A Clinical Investigation to Demonstrate the Performance of a New Enema (TF037) in Distal Bowel Cleansing Compared With Fleet Enema (NCT01715272) | Norgine | 2012-10-01 |
| Hemophilia B Gene Therapy With AAV8 Vector (NCT01620801) | Spark Therapeutics, Inc. | 2012-10-01 |
| Mindfulness-Based Cognitive Therapy for Perinatal Women With Mood Disorders (NCT02150681) | University of California, Los Angeles | 2012-10-01 |
| Routes of Immunization and Flu Immune Responses (NCT01707602) | Assistance Publique - Hôpitaux de Paris | 2012-10-01 |
| T Regulatory Lymphocytes (Treg) Depletion for Cancer Treatment Efficacy and Safety Study (NCT00986518) | Assistance Publique - Hôpitaux de Paris | 2012-10-01 |
| First In Human Study on Synthetic Surfactant CHF 5633 in Respiratory Distress Syndrome (NCT01651637) | Chiesi Farmaceutici S.p.A. | 2012-10-01 |
| Bioequivalence Study of Amlodipine / Losartan/ Hydrochlorothiazide of PHARMALINE, Lebanon Under Fastion Conditions (NCT01713647) | Pharmaceutical Research Unit, Jordan | 2012-10-01 |
| Prolonged Popliteal Fossa Nerve Blockade (Prolonged Pop) (NCT02198235) | Hospital for Special Surgery, New York | 2012-10-01 |
| An Open Label, International, Multi-centre, Phase I/IIa Study of Lenalidomide (Revlimid) and Romidepsin (Istodax) for Relapsed /Refractory Hodgkin Lymphoma, Mature T-cell Lymphoma and Multiple Myeloma. (RId Study) (NCT01742793) | Yale University | 2012-10-01 |
| A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer (NCT01647828) | OncoMed Pharmaceuticals, Inc. | 2012-10-01 |
| NUC-1031 in Patients With Advanced Solid Tumours (NCT01621854) | Imperial College London | 2012-10-01 |
| Effect of P-glycoprotein Inhibition on Lenalidomide Pharmacokinetics in Healthy Males (NCT01712828) | Celgene | 2012-10-01 |
| A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer (NCT01715168) | Azaya Therapeutics, Inc. | 2012-10-01 |
| Evaluation of Patient Performance Using the Metoject Device for Subcutaneous Injection in Rheumatoid Arthritis (RA)Patient (NCT01871961) | medac GmbH | 2012-10-01 |
| Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes Mellitus (NCT01673178) | Pfizer | 2012-10-01 |
| Safety and Tolerability of MRZ-99030 Eye Drops in Healthy Volunteers and Glaucoma Patients (NCT01714960) | Merz Pharmaceuticals GmbH | 2012-10-01 |
| Safety and Efficacy of the Inspiromatic Inhaler in Comparison to the Aerolizer Inhaler When Delivering Formoterol (NCT01711086) | Guy Steuer | 2012-10-01 |
| Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy (NCT01727973) | Sun Yat-sen University | 2012-10-01 |
| MAS-1 Adjuvanted Compared to Unadjuvanted Influenza Vaccines in the Elderly (NCT01623232) | US Department of Veterans Affairs | 2012-10-01 |
| A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), Food Effect of AMG 357 in Healthy Subjects (NCT01695876) | Amgen | 2012-10-01 |
| Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fed Conditions (NCT01827878) | IPCA Laboratories Ltd. | 2012-10-01 |
| Explorative Efficacy Profile of Neurexan® in an Experimental Acute Stress Setting in Healthy Subjects (NCT01703819) | Biologische Heilmittel Heel GmbH | 2012-10-01 |
| Mesenchymal Stem Cell Therapy in Multiple System Atrophy (NCT02315027) | Mayo Clinic | 2012-10-01 |
| RSV-F Vaccine and Influenza Vaccine Co-Administration Study in the Elderly (NCT01709019) | Novavax | 2012-10-01 |
| Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008) (NCT01678807) | ALK-Abelló A/S | 2012-10-01 |
| A Trial Investigating the Safety, Tolerability, and Distribution and Activity in the Body of NNC0148-0000-0287 Injected Under the Skin in Healthy Subjects and in Subjects With Type 1 Diabetes (NCT01730014) | Novo Nordisk A/S | 2012-10-01 |
| Safety and Pharmacokinetics Study of FBF001 (NCT02295813) | Fab'entech | 2012-10-01 |
| Exposure of Naive and Pre-immune Subjects to P. Vivax Challenge (NCT01585077) | Socrates Herrera Valencia | 2012-10-01 |
| Protective Effects of Remote Limb Ischemic Preconditioning on Acute Cerebral Infarction (NCT01672515) | Capital Medical University | 2012-10-01 |
| Pharmacokinetics of BAF312 in Patients With Hepatic Impairment (NCT01565902) | Novartis Pharmaceuticals | 2012-10-01 |
| A Open-label, Three-period, Partial-replicate Design Study to Evaluate the Inter- and Intrasubject Variability of the Avatrombopag To-be-marketed Formulation Administered as Single Doses of 40 mg to Healthy Subjects Receiving a Low-fat Meal (NCT01759394) | Eisai Inc. | 2012-10-01 |
| Evaluation of the Effect of ATX-101 on QT/QTc Intervals (NCT01706679) | Kythera Biopharmaceuticals | 2012-10-01 |
| Taste and Palatability of Orfadin Suspension (NCT01734889) | Swedish Orphan Biovitrum | 2012-10-01 |
| First Study to Evaluate the Capacity of Maraviroc Drug to Protect Against HIV Infection in Samples of Rectal Mucosa From Healthy Volunteers (NCT01719627) | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 2012-10-01 |
| A Phase I Safety, Pharmacokinetics and Pharmacodynamics Study of Recombinant Factor VIIa in Adult Patients With Hemophilia A or B (NCT01708564) | rEVO Biologics | 2012-10-01 |
| A Phase I Multiple Ascending Dose Study of ASLAN002 in Subjects With Advanced or Metastatic Solid Tumours (NCT01721148) | ASLAN Pharmaceuticals | 2012-10-01 |
| Sleep Effectiveness and Insulin and Glucose Homeostasis (NCT01887691) | Beth Israel Deaconess Medical Center | 2012-10-01 |
| Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer (NCT01642732) | University of Michigan Rogel Cancer Center | 2012-10-01 |
| A Study To Test The Safety, Amount And Effects Of PF-06282999 In Healthy Overweight Adults And A Study To Test The Effects Of PF-06282999 On The Amount Of The Approved Drug, Midazolam, In Healthy Adults (NCT01707082) | Pfizer | 2012-10-01 |
| Myocet ® - Carboplatine in Ovarian Cancer in Relapse, Sensitive to the Platinum (NCT01705158) | ARCAGY/ GINECO GROUP | 2012-10-01 |
| A Pharmacokinetics Study of Aleglitazar in Combination With Digoxin in Healthy Volunteers (NCT01701739) | Hoffmann-La Roche | 2012-10-01 |
| Versartis Trial in Children to Assess Long-Acting Growth Hormone (NCT01718041) | Versartis Inc. | 2012-10-01 |
| Pharmacokinetic Properties of Lu AA21004 (Vortioxetine) in Healthy Young Chinese Men and Women (NCT01676571) | H. Lundbeck A/S | 2012-10-01 |
| A Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Multiple Oral Doses Of PF-04895162 (NCT01691274) | Pfizer | 2012-10-01 |
| Reducing Drug Use and HIV Risk in Drug-dependent Adults Arrested for Prostitution (NCT01560221) | Johns Hopkins University | 2012-10-01 |
| Lintuzumab-Ac225 in Older Acute Myeloid Leukemia (AML) Patients (NCT02575963) | Actinium Pharmaceuticals | 2012-10-01 |
| Safety of Autologous M2 Macrophage in Treatment of Non-Acute Stroke Patients (NCT01845350) | Siberian Branch of the Russian Academy of Medical Sciences | 2012-10-01 |
| Bioequivalence Study of Etodolac Capsules USP 300 mg Under Fasting Condition (NCT01746719) | IPCA Laboratories Ltd. | 2012-10-01 |
| Docetaxel, Gemcitabine and Pazopanib as Treatment for Soft Tissue Sarcoma (NCT01719302) | University of Vermont | 2012-10-01 |
| A Safety and Immunogenicity Phase I Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid (NCT01707069) | Immunomic Therapeutics, Inc. | 2012-10-01 |
| Evaluation of the IPS System for TLD Therapy in Patients With COPD (NCT01716598) | Nuvaira, Inc. | 2012-10-01 |
| Pharmacokinetics (PK) and Tolerability of AVP-786 in Healthy Volunteers (NCT01787747) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2012-10-01 |
| A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of Genz-682452 in Healthy Volunteers (NCT01710826) | Genzyme, a Sanofi Company | 2012-10-01 |
| A Open-label, Single-dose, 2-Sequence, 2-Period, Crossover Study to Assess Safety and Pharmacokinetics of a Nateglinide/Metformin HCl Combined Tablet Compared With a Nateglinide 120 mg Tablet and Metformin HCl 500 mg Tablet Under Fasting Conditions in Healthy Male Subjects (NCT02088918) | IlDong Pharmaceutical Co Ltd | 2012-10-01 |
| Randomized Controlled Trial of the Meaning-Making Intervention (MMi) (NCT01693991) | Jewish General Hospital | 2012-10-01 |
| TP0502-Pharmaco-Scintigraphic-Study and Amendment (NCT02306785) | Tillotts Pharma AG | 2012-10-01 |
| A Study to Assess the Absolute Bioavailability and Pharmacokinetics of Simeprevir (TMC435) Administered as Single Oral Doses of TMC435 and an Intravenous Microdose of [3H]-TMC435 in Healthy Male Patients (NCT01707342) | Janssen R&D Ireland | 2012-10-01 |
| A Trial Comparing the Effect of Exercise on Blood Glucose in Subjects With Type 1 Diabetes, Who Are Treated With Either Insulin Degludec or Insulin Glargine (NCT01704417) | Novo Nordisk A/S | 2012-10-01 |
| A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® Gel 3% in the Treatment of Actinic Keratosis (NCT01742663) | Sun Pharmaceutical Industries, Inc. | 2012-10-01 |
| A Study to Investigate the Absorption, Metabolism, and Excretion of JNJ-38518168 After a Single Oral Dose in Healthy Male Participants. (NCT01970020) | Janssen Research & Development, LLC | 2012-10-01 |
| Kuvan in People With Schizophrenia and Schizoaffective Disorder (NCT01706965) | New York State Psychiatric Institute | 2012-10-01 |